Clinical Trials · NCT00734474
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 1,202
- Start date
- Aug 2008
- Locations
- 99 sites, 13 countries
- Primary endpoint
- Glycosylated Hemoglobin (HbA1c) Change From Baseline